- Home
- Automated
- List of product information
- PANBESY CAPSULE 30 MG [SIN05113P]
PANBESY CAPSULE 30 MG [SIN05113P]
Active ingredients: PANBESY CAPSULE 30 MG
Last updated 26 October 2025
Product Info
PANBESY CAPSULE 30 MG
[SIN05113P]
Product information
Active Ingredient and Strength | PHENTERMINE HCL - 30 MG |
Dosage Form | CAPSULE |
Manufacturer and Country | OSMOPHARM SA - SWITZERLAND |
Registration Number | SIN05113P |
Licence Holder | EURODRUG LABORATORIES SINGAPORE PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | A08AA01 |
INDICATIONS
For short term use as an adjunct to the treatment of some patients with moderate to severe obesity.
RECOMMENDED DOSAGE
Adult: 1–2 capsules of 15 mg a day before breakfast.
Adult: 1 capsule of 30 mg a day before breakfast.
CONTRAINDICATIONS
Epilepsy; hypersensitivity to sympathomimetic amines; advanced arteriosclerosis; severe hypertension; children under 12 years; hyperexcitability; patients with cardiovascular disease; hyperthyroidism; glaucoma.
Patients with a history of drug abuse. During or 14 days following administration of monoamine oxidase inhibitors.